Annovis Bio, Inc.
ANVS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001477845
No open-market purchases or sales by Annovis Bio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $20.2M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Annovis Bio, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −4 vs. Q4 2023
- Shares held
- 1.21M
- +18.5K (+1.6%) vs. Q4 2023
- Total value
- $14.3M
- −$8.05M (−36.0%) vs. Q4 2023
- New holders
- 6
- 12 more added
- Sold out
- 10
- 6 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $20.2M |
| Q1 2026 | 56 | $10.5M |
| Q4 2025 | 53 | $14.7M |
| Q3 2025 | 42 | $4.19M |
| Q2 2025 | 42 | $3.93M |
| Q1 2025 | 44 | $3.13M |
| Q4 2024 | 40 | $7.93M |
| Q3 2024 | 35 | $9.50M |
| Q2 2024 | 31 | $5.67M |
| Q1 2024 | 31 | $14.3M |
| Q4 2023 | 36 | $22.5M |
| Q3 2023 | 30 | $10.6M |
| Q2 2023 | 28 | $18.3M |
| Q1 2023 | 23 | $11.6M |
| Q4 2022 | 23 | $9.93M |
| Q3 2022 | 25 | $10.0M |
| Q2 2022 | 26 | $8.73M |
| Q1 2022 | 24 | $11.9M |
| Q4 2021 | 32 | $19.6M |
| Q3 2021 | 38 | $36.2M |
| Q2 2021 | 57 | $109.0M |
| Q1 2021 | 31 | $23.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Annovis Bio, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 4 | $0 | 0.00% | −36−90.0% | Reduced |
| Citadel Advisors LLC | 1 | $12 | 0.00% | +1 | New |
| WR Wealth Planners, LLC | 150 | $1.78K | 0.00% | +150 | New |
| Game Plan Financial Advisors, LLC | 200 | $2.38K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 400 | $4.00K | 0.00% | −200−33.3% | Reduced |
| UBS Group AG | 600 | $7.14K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,200 | $14.3K | 0.00% | 00.0% | Unchanged |
| Quest Partners LLC | 3,340 | $39.7K | 0.01% | +3,340 | New |
| Tower Research Capital LLC (TRC) | 4,798 | $57.1K | 0.00% | +4,376+1,037.0% | Added |
| Bank of America Corp | 5,514 | $65.6K | 0.00% | +2,245+68.7% | Added |
| Morgan Stanley | 7,156 | $85.2K | 0.00% | +5,722+399.0% | Added |
| Wells Fargo & Company | 8,801 | $104.7K | 0.00% | +10.0% | Added |
| Merit Financial Group, LLC | 22,200 | $115.0K | 0.00% | 00.0% | Unchanged |
| Wealthspire Advisors, LLC | 10,000 | $119.0K | 0.00% | −990−9.0% | Reduced |
| Cetera Investment Advisers | 11,175 | $133.0K | 0.00% | +11,175 | New |
| Lokken Investment Group LLC | 12,235 | $145.6K | 0.07% | +12,235 | New |
| Greenwich Wealth Management LLC | 12,575 | $150.0K | 0.01% | +2,300+22.4% | Added |
| Spears Abacus Advisors LLC | 15,000 | $178.5K | 0.00% | +15,000 | New |
| Bank of New York Mellon Corp | 19,059 | $226.8K | 0.00% | −1,646−7.9% | Reduced |
| Northern Trust Corp | 24,267 | $288.8K | 0.00% | −4,781−16.5% | Reduced |
| State Street Corp | 29,135 | $346.7K | 0.00% | +5,600+23.8% | Added |
| Modera Wealth Management, LLC | 30,513 | $363.1K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 33,600 | $399.8K | 0.01% | +10,000+42.4% | Added |
| Sterling Investment Advisors, Ltd. | 34,374 | $409.1K | 0.11% | 00.0% | Unchanged |
| Redmond Asset Management, LLC | 36,157 | $430.3K | 0.14% | +2,077+6.1% | Added |
| Wescott Financial Advisory Group, LLC | 41,607 | $495.1K | 0.06% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 70,791 | $842.6K | 0.00% | +2,015+2.9% | Added |
| Susquehanna International Group, LLP | 72,602 | $864.0K | 0.00% | +56,830+360.3% | Added |
| BlackRock Inc. | 97,629 | $1.16M | 0.00% | +1,645+1.7% | Added |
| Adage Capital Partners GP, L.L.C. | 250,000 | $2.98M | 0.01% | −35,347−12.4% | Reduced |
| Vanguard Group Inc | 357,942 | $4.26M | 0.00% | +20,588+6.1% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −32,582−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,282−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,969−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −11,197−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −11,095−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,588−100.0% | Sold out |
| Private Trust Co NA | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −302−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| Cannell Peter B & Co Inc | – | – | – | – | Not filed |